NCT04730271

Brief Summary

The purpose of this post-market research study is to gather clinical and radiographic (X-ray) information about total knee replacement surgeries completed with the VELYS Robotic-Assisted Solution and with standard manual instrumentation. The VELYS Robotic-Assisted Solution helps the surgeon to plan bone cuts and then accurately achieve the planned cuts during the total knee replacement surgery. The study aims to compare how well the VELYS Robotic-Assisted system enables the surgeon to position the implants exactly as planned compared to manual instrumentation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2021

Typical duration for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 29, 2021

Completed
25 days until next milestone

Study Start

First participant enrolled

February 23, 2021

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2023

Completed
10 months until next milestone

Results Posted

Study results publicly available

July 11, 2024

Completed
Last Updated

April 27, 2025

Status Verified

April 1, 2025

Enrollment Period

2.1 years

First QC Date

January 26, 2021

Results QC Date

April 4, 2024

Last Update Submit

April 25, 2025

Conditions

Keywords

ArthroplastyKneeRobotic-AssistedVELYSAccuracy

Outcome Measures

Primary Outcomes (1)

  • Accuracy of the Hip-Knee-Ankle Angle (HKA) Measured on Long-leg X-rays at 12 Weeks.

    The primary objective of this clinical investigation is to evaluate whether the accuracy to plan of the long leg alignment achieved with VELYS Robotic-Assisted Solution is non-inferior to the accuracy to plan of the long leg alignment achieved with the manual ATTUNE Intuition instrumentation. This will be assessed by measuring the Hip-Knee-Ankle angle (HKA) on long-leg X-rays taken at 12 weeks and comparing to the planned HKA. A smaller number represents improved accuracy and a better outcome.

    12 weeks

Secondary Outcomes (6)

  • Accuracy of the Distal Femoral Varus-valgus Angle Measured on Long Leg X-rays at 12 Weeks.

    12 weeks

  • Accuracy of the Proximal Tibial Varus-valgus Angle Measured on Long-leg X-rays at 12 Weeks

    12 weeks

  • Accuracy of Femoral Component Flexion Angle Measured on Lateral X-rays at 12 Weeks

    12 weeks

  • Accuracy of the Tibial Slope Angle Measured on Lateral X-rays at 12 Weeks

    12 weeks

  • Type and Frequency of Adverse Events

    12 weeks, 1 year

  • +1 more secondary outcomes

Other Outcomes (10)

  • EuroQol 5-Dimension 5-Level (EQ-5D-5L) - Change From Baseline

    1 year

  • Forgotten Joint Score (FJS-12)

    12 weeks and 1 year

  • Knee Injury and Osteoarthritis Outcome Score (KOOS) ADL - Change From Baseline

    12 weeks, 1 year

  • +7 more other outcomes

Study Arms (2)

Manual Arm

ACTIVE COMPARATOR

Subjects enrolled into this arm of the study will receive an ATTUNE primary total knee replacement that has been implanted using manual instrumentation which is the current standard of care at the participating sites.

Device: Total Knee Replacement

Robotic-Assisted Arm

EXPERIMENTAL

Subjects enrolled into this arm will receive an ATTUNE primary total knee replacement that has been implanted with the use of the VELYS Robotic-Assisted Solution device.

Device: Total Knee Replacement

Interventions

Subjects will be implanted with an ATTUNE Primary total knee replacement.

Manual ArmRobotic-Assisted Arm

Eligibility Criteria

Age22 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is male or female and between the ages of 22 and 85 years at the time of consent, inclusive.
  • Subject has a severely painful and/or severely disabled joint resulting from osteoarthritis, post-traumatic arthritis or rheumatoid arthritis and in the opinion of the Investigator, is a suitable candidate for primary TKA using the devices described in this CIP with either resurfaced or non-resurfaced patellae.
  • Subject that is willing to give voluntary, written informed consent to participate in this clinical investigation and authorize the transfer of his/her information to the Sponsor
  • Subject is currently not permanently bedridden, as determined by the Investigator
  • Subject, in the opinion of the Investigator, is able to understand this clinical investigation and is willing and able to perform all study procedures and follow-up visits and co-operate with investigational procedures.
  • Subject is able to read and comprehend the Informed Consent Document as well as complete the required PROs in English.
  • Subject's pre-operative alignment is such that (in the opinion of the Investigator) it is appropriate for it to be adjusted to mechanical long leg alignment during surgery.

You may not qualify if:

  • The Subject is a woman who is pregnant or lactating.
  • Contralateral knee has already been enrolled in this study.
  • Subject had a contralateral amputation.
  • Previous partial knee replacement (unicompartmental, bicompartamental or patellofemoral joint replacement), patellectomy, high tibial osteotomy or primary TKA in affected knee.
  • Subject has an active local or systemic infection
  • Subject has loss of bone or musculature, osteoporosis, neuromuscular compromise or vascular deficiency in the affected limb in sufficient degree to render the procedure unjustifiable in the opinion of the Investigator (e.g. absence of musculo-ligamentous supporting structures, joint neuropathy)
  • Subject has severe instability secondary to advanced loss of osteochondral structure or the absence of collateral ligament integrity.
  • Subject has participated in a clinical investigation with an investigational product (drug or device) in the last three (3) months.
  • Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Sinai Hospital of Baltimore

Baltimore, Maryland, 21215, United States

Location

Cuyuna Regional Medical Center

Crosby, Minnesota, 56441, United States

Location

OrthoCarolina

Charlotte, North Carolina, 28207, United States

Location

Campbell Clinic

Germantown, Tennessee, 38138, United States

Location

Proliance Orthopedic Associates

Renton, Washington, 98055, United States

Location

MeSH Terms

Conditions

Osteoarthritis

Interventions

Arthroplasty, Replacement, Knee

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Limitations and Caveats

Adverse events were coded as reported by sites per MeDRA. This resulted in some spreading of AEs. For example, "swelling" and "knee swelling" were coded differently according to best practice. Future publications will consolidate similar coded events and clarify which were combined.

Results Point of Contact

Title
Ian Leslie
Organization
DePuy Synthes

Study Officials

  • Ian J Leslie, PhD

    DePuy Synthes

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
LTE60
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Quantitative analysis of the X-rays will be conducted by a third party who will be blinded to the treatment group.
Purpose
TREATMENT
Intervention Model
SEQUENTIAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 26, 2021

First Posted

January 29, 2021

Study Start

February 23, 2021

Primary Completion

April 7, 2023

Study Completion

September 6, 2023

Last Updated

April 27, 2025

Results First Posted

July 11, 2024

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Johnson \& Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.

More information

Locations